THANOSWITCH
DEAD

Serial Number

90692260

Owner

INZEN THERAPEUTICS, INC.

Attorney

Christina M. Licursi

Filing Date

May 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

THANOSWITCH Trademark

Serial Number: 90692260

THANOSWITCH is a trademark filed by INZEN THERAPEUTICS, INC. on May 5, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

INZEN THERAPEUTICS, INC. (7 trademarks)

55 CAMBRIDGE PARKWAY
CAMBRIDGE, MA 02142

Entity Type: 03

Sonata Therapeutics, Inc. (12 trademarks)

99 Coolidge Ave, Suite 500
Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

May 5, 2021

Registration Date

Not Registered

Published for Opposition

March 28, 2023

Goods & Services

Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules for medical use, for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine

Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 26, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 25, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 23, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 28, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2023 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 4, 2023 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 8, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 8, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 8, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 11, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 6, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2021 NWOS